Get the Stockscreener App
144.64
3.91%
-5.89
After Hours:
144.64
Overview
News
Price History
Option Chain
Financials
Why MASI Down?
Discussions
Forecast
Dividend History
Masimo Corp stock is traded at $144.64, with a volume of 591.87K.
It is down -3.91% in the last 24 hours and down -0.81% over the past month.
Masimo Corp is a technology company. The company's segment includes healthcare and non-healthcare. The healthcare business segment is a key revenue driver, develops, manufactures, and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. Its non-healthcare segment includes consumer audio business develops, manufactures, markets sells and licenses premium and luxury audio sound products and related integration technologies.
See More
Previous Close:
$150.53
Open:
$151.13
24h Volume:
591.87K
Relative Volume:
0.84
Market Cap:
$7.86B
Revenue:
$1.97B
Net Income/Loss:
$-494.50M
P/E Ratio:
-15.69
EPS:
-9.22
Net Cash Flow:
$137.20M
1W Performance:
-1.80%
1M Performance:
-0.81%
6M Performance:
-4.52%
1Y Performance:
+1.87%
1-Day Range:
$144.10
$151.16
1-Week Range:
$144.10
$155.99
52-Week Range:
$133.70
$194.88
Masimo Corp Stock (MASI) Company Profile
Name
Masimo Corp
Sector
Industry
Phone
949-297-7000
Address
52 DISCOVERY, IRVINE, CA
Compare MASI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MASI
Masimo Corp
|
144.64 | 8.18B | 1.97B | -494.50M | 137.20M | -9.22 |
|
ABT
Abbott Laboratories
|
132.57 | 232.02B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
95.41 | 144.14B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.60 | 141.53B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.45 | 123.78B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
73.94 | 44.14B | 5.69B | 1.41B | 577.90M | 6.9828 |
Masimo Corp Stock (MASI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-27-24 | Reiterated | Raymond James | Outperform |
| Nov-06-24 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jun-03-24 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-15-24 | Upgrade | Stifel | Hold → Buy |
| Mar-25-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-24 | Downgrade | Jefferies | Buy → Hold |
| Jan-03-24 | Downgrade | Needham | Buy → Hold |
| Nov-08-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-18-23 | Downgrade | Stifel | Buy → Hold |
| Jul-10-23 | Initiated | Wells Fargo | Equal Weight |
| Feb-22-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-15-22 | Upgrade | BTIG Research | Neutral → Buy |
| Dec-05-22 | Reiterated | Needham | Buy |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Sep-15-22 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Sep-14-22 | Initiated | Loop Capital | Buy |
| Apr-06-22 | Initiated | Wolfe Research | Peer Perform |
| Feb-18-22 | Upgrade | Needham | Hold → Buy |
| Feb-16-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Oct-12-21 | Resumed | Raymond James | Mkt Perform |
| Sep-02-20 | Initiated | Robert W. Baird | Outperform |
| Aug-14-20 | Resumed | Piper Sandler | Overweight |
| Apr-20-20 | Downgrade | Needham | Buy → Hold |
| Mar-02-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-07-19 | Reiterated | Needham | Buy |
| Apr-16-19 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-19 | Reiterated | Needham | Buy |
| Dec-19-18 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Sep-14-18 | Initiated | Needham | Buy |
| Mar-09-18 | Initiated | Barclays | Overweight |
| Aug-14-17 | Upgrade | BTIG Research | Neutral → Buy |
| Apr-04-17 | Reiterated | Wedbush | Outperform |
| Mar-16-17 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Feb-27-17 | Reiterated | Wedbush | Outperform |
| Feb-13-17 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-04-16 | Reiterated | Wedbush | Outperform |
| May-05-16 | Upgrade | Piper Jaffray | Neutral → Overweight |
| May-05-16 | Reiterated | Wedbush | Outperform |
| Jan-06-16 | Downgrade | Raymond James | Strong Buy → Outperform |
| Aug-05-15 | Reiterated | ROTH Capital | Buy |
View All
Masimo Corp Stock (MASI) Latest News
Masimo Corp. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Dec 3, 2025 Investor Day — Masimo presents growth strategy, innovation pipeline & long-term outlook - Stock Titan
Zero occult hypoxemia — Masimo INSPIRE feasibility study shows 1.47% ARMS accuracy in ICU patients - Stock Titan
Why Masimo (MASI) is a Top Growth Stock for the Long-Term - Yahoo Finance
Is the Options Market Predicting a Spike in Masimo Stock? - Yahoo Finance
Masimo (MASI): Assessing Valuation Amid Recent Performance Signals - simplywall.st
Masimo Corporation (NASDAQ:MASI) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Conflict waiver shields Quinn Emanuel in Masimo shareholder suit - Daily Journal
With Sound United Gone, Masimo Files SEC Report Recasting Last 3 Years of Financials - Strata-gee.com
Apple Secures Victory In Masimo Patent Dispute With Token Damages Of $250 - MSN
3 Reasons MASI is Risky and 1 Stock to Buy Instead - The Globe and Mail
What analysts say about Masimo Corporation stockEnergy Sector Updates & Affordable Market Insights - earlytimes.in
Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Barchart.com
Should You Add Inspirisys Solutions Limited Stock to Your Portfolio NowTechnical Pattern Recognition & Small Capital Growth Stocks - earlytimes.in
Masimo files pro forma financials after sale of consumer audio business to Harman - Investing.com
Masimo Corporation Securities Lawsuit Investigation - Claim Depot
Can you recover from losses in Masimo Corporation2025 Geopolitical Influence & AI Based Buy/Sell Signal Reports - newser.com
Will Masimo Corporation (3M4) stock deliver compounding returnsMarket Weekly Review & Long-Term Safe Investment Plans - newser.com
How risky is Masimo Corporation stock nowEarnings Miss & Technical Entry and Exit Alerts - newser.com
Will Masimo Corporation (3M4) stock hit analyst forecasts2025 Bull vs Bear & Expert-Curated Trade Recommendations - newser.com
Masimo Corporation (MASI): A Bull Case Theory - Yahoo Finance
Masimo (NASDAQ:MASI) Upgraded at Wall Street Zen - MarketBeat
How Masimo Corporation (3M4) stock benefits from digital adoptionTrade Exit Summary & Weekly High Potential Alerts - newser.com
Will Masimo Corporation (3M4) stock profit from AI boomOptions Play & Community Consensus Picks - newser.com
Samsung’s Harman Acquires Masimo Audio Brands for $350M Boost - WebProNews
Is Masimo Corporation (3M4) stock supported by free cash flowMarket Growth Report & Daily Volume Surge Signals - newser.com
Judge Plans To Let ITC Take Lead In Apple Watch Patent Fight - Law360
Don't Overlook These 2 Highly Ranked Medical Stocks: COLL, MASI - Yahoo Finance
Apple Watch Imports at Risk if ITC Fails to Act, Judge Warns (1) - Bloomberg Law News
Masimo Completes Divestment of Consumer Audio Business to HARMAN - The Globe and Mail
Neonatal Infant Care Market Size Worth USD 6.70 Billion by 2034 Driven by Rising Preterm Birth Rates and Growing Demand for Advanced NICU Technologies - GlobeNewswire Inc.
Swedbank AB Trims Stock Position in Masimo Corporation $MASI - MarketBeat
Perpetual Ltd Sells 9,037 Shares of Masimo Corporation $MASI - MarketBeat
Masimo Sells Sound United to HARMAN for $328M - The Globe and Mail
Masimo Completes Sale of Sound United to Harman International - Strata-gee.com
Harman completes acquisition of Sound United from Masimo By Investing.com - Investing.com South Africa
Masimo Completes $350M Sale of Consumer Audio Unit - Orange County Business Journal
Masimo completes sale of Sound United to HARMAN - Investing.com
Harman completes acquisition of Sound United from Masimo - Investing.com
Major Healthcare Tech Pivot: Masimo Sells Sound United to Samsung's HARMAN to Focus on Core Medical Business - Stock Titan
Harbor Capital Advisors Inc. Invests $4.44 Million in Masimo Corporation $MASI - MarketBeat
Masimo Corp Stock (MASI) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.83%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):